Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Metformin may lower PSA levels, possibly affecting prostate cancer development.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

Platelet-rich plasma can improve erectile function in older individuals by reducing prostate enlargement.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

% free PSA and urinary markers help better identify prostate cancer.

Testosterone replacement therapy, especially intramuscular, raises PSA levels, but no overall link between PSA and testosterone was found except in non-BPH patients.

Hair loss gene linked to prostate issues.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

Higher DHT in male baldness may protect against prostate cancer.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Prostate size varies by ethnic group, age, residence, and blood glucose, but not by body measurements or fat.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Computational methods help design drugs targeting prostate cancer proteins.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Large prostates link to more hair loss.

Finasteride treats hair loss but may affect prostate cancer detection.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.